Biotech

All Articles

OS Treatments refiles $6M IPO to cash HER2 medication, preclinical ADCs

.Operating system Therapies are going to detail on the NYSE American sell exchange this morning thro...

ALX's fizzling CD47 action fee delivers stock spiraling down

.ALX Oncology's phase 2 stomach cancer feedback fee has actually diminished. After finding its CD47 ...

Ionis centers eye condition from targets of Roche-partnered prospect after records dissatisfy

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has disappointed requirements, cu...

Biogen's CEO stated no unsafe handle 2023. He prepares to be daring

.While Biogen's pharma peers are hunting for late-stage possessions along with little bit of risk, C...

Instil refills pipe in $2B biobucks cope with ImmunOnco

.Instil Biography has actually been a biotech seeking a pipeline after it ditched its lead propertie...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually restored civil rights to a very early Alzheimer's illness program to Denali Reh...

Takeda taps brand new head people oncology business-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial management hirings, firings an...

Vertex, hammered through AATD once more, goes down 2 properties on throw away heap

.Vertex's attempt to address an uncommon hereditary condition has actually attacked an additional tr...

Vir increases 3 T-cell engagers from Sanofi, gives up 25% of staff

.Vir Biotechnology's second-quarter revenues report wasn't except big updates. The firm accepted a t...

Galapagos pauses CAR-T cell therapy trial over Parkinsonism situation

.Galapagos has stopped enrollment in a test of a BCMA-directed CAR-T tissue treatment, pushing the b...